Case Report of Rituximab-induced Thrombocytopenia [2]

American Journal of Hematology

Volumn 75, Issue 4, 2004, Pages 263-

  Shah, Chirag ^a   Grethlein, Sara J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ADULT; ANTIGEN ANTIBODY REACTION; BONE MARROW CELL; CASE REPORT; COMPLEMENT ACTIVATION; DRUG INDUCED DISEASE; HUMAN; LETTER; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 1842583979     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20028     Document Type: Letter

References (2)

1. Staci R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98:952-957
2. Chaiwatanatorn K, Lee N, Grigg A, Filshie R, Firkin F. Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol 2003:121:913-918.